PMC:7299399 / 13206-13441 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T147","span":{"begin":115,"end":116},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T148","span":{"begin":142,"end":149},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T149","span":{"begin":176,"end":179},"obj":"http://purl.obolibrary.org/obo/CLO_0037067"},{"id":"T150","span":{"begin":208,"end":215},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T151","span":{"begin":223,"end":226},"obj":"http://purl.obolibrary.org/obo/CLO_0037067"}],"text":"CoV-2). The various approaches developed over the years are mainly based on the creation of entry inhibitors.40,41 A highly conserved part in viruses is the attachment ligand (VAL). In most known respiratory viruses,42 the VAL targets "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T59","span":{"begin":98,"end":108},"obj":"Chemical"},{"id":"T60","span":{"begin":168,"end":174},"obj":"Chemical"}],"attributes":[{"id":"A59","pred":"chebi_id","subj":"T59","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A60","pred":"chebi_id","subj":"T60","obj":"http://purl.obolibrary.org/obo/CHEBI_52214"}],"text":"CoV-2). The various approaches developed over the years are mainly based on the creation of entry inhibitors.40,41 A highly conserved part in viruses is the attachment ligand (VAL). In most known respiratory viruses,42 the VAL targets "}

{"project":"LitCovid-sentences","denotations":[{"id":"T65","span":{"begin":8,"end":181},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"CoV-2). The various approaches developed over the years are mainly based on the creation of entry inhibitors.40,41 A highly conserved part in viruses is the attachment ligand (VAL). In most known respiratory viruses,42 the VAL targets "}

{"project":"LitCovid-PubTator","denotations":[{"id":"221","span":{"begin":196,"end":207},"obj":"Species"},{"id":"222","span":{"begin":176,"end":179},"obj":"Chemical"},{"id":"223","span":{"begin":223,"end":226},"obj":"Chemical"}],"attributes":[{"id":"A221","pred":"tao:has_database_id","subj":"221","obj":"Tax:12814"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"CoV-2). The various approaches developed over the years are mainly based on the creation of entry inhibitors.40,41 A highly conserved part in viruses is the attachment ligand (VAL). In most known respiratory viruses,42 the VAL targets "}